Anzeige
Mehr »
Login
Mittwoch, 08.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Warum der Warren Buffett des Bergbaus alles auf diese Aktie setzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
754 Leser
Artikel bewerten:
(2)

ENOGIA: 2023 half-year results

Finanznachrichten News

DJ ENOGIA: 2023 half-year results

ENOGIA 
ENOGIA: 2023 half-year results 
18-Oct-2023 / 17:40 CET/CEST 
Dissemination of a French Regulatory News, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
 
2023 half-year results 
 
 - Revenue up 126% (EUR2.4 million), in line with the acceleration of sales momentum 
 
 - Start of an operational efficiency plan, 
  with full impact on profitability in 2024 
 
 - Confirmation of targets of 
  50% annual revenue growth over three years 
  and positive free cash flow by 2025 
 
 
Marseille, 18 October 2023 - 6 p.m. 
ENOGIA (ISIN code: FR0014004974 - ticker: ALENO, an expert in micro-turbomachinery for the energy transition, is 
reporting its half-year results for the first half of 2023, approved by the Board of Directors on 18 October 2023, and 
providing an update on its recent strategic and financial milestones. 
Since the start of the year, ENOGIA has worked simultaneously on number of defining initiatives. The Company has 
launched an operational efficiency plan and strengthened its financial structure and governance, while continuing to 
pursue sustained sales momentum and the performance of ongoing contracts. 
The financial structure was strengthened in July by a capital increase with preferential subscription rights of 
approximately EUR4.6 million. This successful fundraising, oversubscribed 1.7 times, was accompanied by the arrival of 
two strategic investors, Éric Blanc-Garin and Yazid Sabeg, who now hold 11.93% of the capital and 8.58% of the voting 
rights (via their joint holding company Duna & Cie). Éric Blanc-Garin and Yazid Sabeg are seasoned entrepreneurs, 
having gained their experience at the head of the CS Group. They have agreed to put their expertise at ENOGIA's service 
by joining the Company's Board of Directors. 
This strengthening of its financial position, shareholder base and governance provides ENOGIA with the resources it 
needs to accelerate its growth and move towards profitability. On the operational efficiency front, ENOGIA rolled out a 
plan built on three main pillars in the first half of 2023. The first pillar was a reorganisation and tightening of 
teams, with the introduction of a leaner organisation, the creation of a dedicated "ORC Standard" business unit, and 
the refocusing of the turbomachinery business on the provision of services. The second pillar was a reduction in the 
breakeven point by reducing fixed expenses: after EUR1 million in savings (on an annual basis) already achieved in the 
first half of 2023 by adjusting headcount, reducing overheads and optimising marketing costs, around EUR0.5 million in 
additional savings are planned for the second half of the current year. Lastly, the third pillar of this operational 
efficiency plan was based on a significant improvement in the gross margin on ORC projects, notably thanks to 
production in longer series, product re-engineering and supplier negotiations. The full impact of this improvement in 
gross margin is expected in 2024, from projects signed in the second half of 2023. 
 
Strong sales momentum and new ORC contract in Germany 
Building robust profitability over the long term will require increased operational efficiency combined with sustained 
sales activity. The good momentum that began in the second half of 2022 has been confirmed since the start of the year. 
The first half saw the signing of an initial order for ORC modules as part of the new Green Shield offer (economy of 
use). This ten-year electricity sales (PPA model) and maintenance services contract with an agricultural grouping in 
Normandy, covering the recovery of waste heat from an anaerobic digestion plant, is the result of a joint investment 
with partner Eiffel Gaz Vert. 
In the vast market for the decarbonisation of the maritime sector, which is a key environmental challenge, ENOGIA was 
selected in the spring as part of a consortium led by South Korea's STX Engine; the Company is responsible for 
supplying a turbomachine that will be integrated into a system for sequestering ship exhaust gases. This sector, which 
is subject to new regulations, also presents major opportunities for the sale of ORC modules. 
On current contracts, the rollout in Germany of the largest anaerobic digestion plant has gathered pace, with the 
commissioning of 10 ORC modules in August 2023. Delivery of the next 30 machines is scheduled for the second half of 
2023, with completion in early 2024. Moreover, this referencing has already led to the sale of four other ORC modules 
for agricultural biogas in Germany. 
 
2023 half-year results 
In EUR thousands           H1 2022 H1 2023 Change 
Revenue              1,041  2,353  +1,311 
Operating income          2,251  3,329  +1,078 
EBITDA[1]             (1,534) (1,497) +37 
Operating profit/(loss)      (2,171) (2,216) -45 
Net financial income/(expense)   (40)  (76)  -36 
Net exceptional income/(expenses) 255   389   +134 
Tax credits            189   96   -93 
Net profit/(loss)         (1,767) (1,807) -40 

In the first half of 2023, the Company recorded revenue of EUR2.4 million, 96% of which from exports (compared with 83% for the same period in 2022). It achieved growth of 126%, benefiting in part from a favourable comparison base after a first half marked by the freezing of the Chinese contract in 2022, as well as from progress on the German contract.

The ORC Modules business more than doubled to EUR2.2 million (+137%) in the first half of 2023. The turbomachinery division recorded revenue of EUR0.13 million, an increase of 26%.

Over the first six months, operating income increased by 47.9%. This is the result of strong business growth, while capitalised production fell by 21.5% to EUR0.84 million, due to the adjustment of R&D investment in Hydrogen.

Purchases and external expenses were up 16.5% at EUR2.6 million, reflecting the performance of the German contract. Personnel expenses were down 3.5% at EUR1.3 million, reflecting the initial impact of the operational efficiency plan launched in the first half of 2023. First-half EBITDA was EUR(1.5) million and the operating loss was EUR2.2 million. After taking into account the research tax credit of EUR0.1 million, the net profit was EUR1.8 million, the same level as in the first half of 2022.

Three-year business targets confirmed

EBITDA breakeven targeted for the second half of 2023

More than ever, ENOGIA is operating in an environment rich in opportunities, characterised by unprecedented needs for energy efficiency linked to high energy prices and ecological challenges. At 30 June 2023, the company had a sales pipeline[2] of over EUR140 million and an order book[3] of more than EUR5 million (EUR3.7 million excluding the ORC contract in China), giving it good visibility over the second half.

Over the period, business will be driven by the performance of the German contract, the acceleration of sales of ORC modules and the Green Shield offer, and the ramp-up of turbomachinery development services. ENOGIA remains confident of achieving its target of revenue growth in excess of 50% for the full year in 2023.

In the second half, the path to profitability will be driven by a number of levers: economies of scale linked to the acceleration of activity and series production, improved operating efficiency following the reorganisation, the continued lowering of the breakeven point, and the increase in gross margins - particularly on the German contract. ENOGIA aims to achieve EBITDA breakeven in the second half.

The Company is reiterating all of its medium-term financial targets. Revenue growth is expected to average more than 50% per year in both 2024 and 2025. This growth, combined with the operational efficiency plan that will come fully into play in 2024, should enable us to achieve positive free cash flow from 2025.

Next releases:

Annual revenue on 26 February 2024 after trading

Annual results, 27 March 2024 after trading

About ENOGIA 
ENOGIA responds to the major challenges of the ecological and energy transition with its unique and patented technology 
of compact, light and durable micro-turbomachinery. As the French leader in heat-to-electricity conversion with its 
wide range of ORC modules, ENOGIA enables its customers to produce decarbonised electricity and to recover waste or 
renewable heat. Since 2020, ENOGIA has also been marketing air compressors for Hydrogen Fuel Cells, thereby 
contributing to the development of hydrogen mobility, a booming market. With sales in more than 25 countries, ENOGIA 
continues to prospect for new customers in France and internationally. Founded in 2009 and based in Marseille, ENOGIA 
has some 60 employees involved in the design, production and marketing of environmentally friendly technological 
solutions. ENOGIA's CSR commitment represents an "Advanced" level of performance according to EthiFinance. 
 
ENOGIA is listed on Euronext Growth Paris. 
Ticker: ALENO. ISIN code: FR0014004974. LEI: 969500IANLNITRI3R653. 
 
Contacts 
Enogia                   Actifin 
Antonin Pauchet         Deputy CEO Marianne Py    Actifin 
antonin.pauchet@enogia.com04 84 25 60 17  Investor relations Press relations 
                      mpy@actifin.fr   presse@actifin.fr 
                      01 80 48 25 31   01 56 88 11 16 
 

Find all of ENOGIA's news on https://enogia.com/investisseurs

-----------------------------------------------------------------------------------------------------------------------

[1] EBITDA is operating profit before depreciation, amortisation and provisions, and after capitalised production. It is an aggregate that illustrates a company's ability to finance its operations beyond its financing structure and taxation.

[2] Projects for which a detailed or preliminary estimate has been issued.

[3] Cumulative orders signed less the amount of progress on the contract. Progress is calculated as the ratio between the expenses incurred and the project expenditure budget.

-----------------------------------------------------------------------------------------------------------------------

Regulatory filing PDF file File: 2023 half-year results

1752139 18-Oct-2023 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1752139&application_name=news

(END) Dow Jones Newswires

October 18, 2023 11:40 ET (15:40 GMT)

© 2023 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.